ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Antiviral Study of ACH126, 433 (b-L-Fd4C) in Adults With Lamivudine-resistant Chronic Hepatitis B

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00040144
Recruitment Status : Terminated (Safety concerns)
First Posted : June 25, 2002
Last Update Posted : August 19, 2009
Sponsor:
Information provided by:
Achillion Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : No date given
  Actual Study Completion Date : May 2003